Lutein presents suppressing but not blocking chemopreventive activity during diethylnitrosamine-induced hepatocarcinogenesis and this involves inhibition of DNA damage

Chemico-Biological Interactions

Volumn 168, Issue 3, 2007, Pages 221-228

  Moreno, Fernando Salvador ^a   Toledo, Luciana Passos ^a   de Conti, Aline ^a   Heidor, Renato ^a   Jordão Jr , Alceu ^a   Vannucchi, Hélio ^a   Cardozo, Mônica Testoni ^a   Ong, Thomas Prates ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Blocking agent; Chemoprevention; DNA damage; Hepatocarcinogenesis; Lutein; Suppressing agent

Indexed keywords

CORN OIL; DIETHYLNITROSAMINE; N (2 FLUORENYL)ACETAMIDE; XANTHOPHYLL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER MODEL; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DNA DAMAGE; DRUG CLASSIFICATION; DRUG EFFECT; DRUG MECHANISM; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL; LIVER RESECTION; MALE; NONHUMAN; PRECANCER; RAT; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; BODY WEIGHT; DIETHYLNITROSAMINE; DNA DAMAGE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; LUTEIN; MALE; ORGAN SIZE; RATS; RATS, WISTAR;

ANIMALIA; RATTUS; RATTUS NORVEGICUS; ZEA MAYS;

EID: 34347222521     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2007.04.011     Document Type: Article

References (40)

1. Mc Glynn K.A., and London W.T. Epidemiology and natural history of hepatocellular carcinoma. Best Pract. Res. Clin. Gastroenterol. 19 (2005) 3-23
2. Kensler T.W., Quian G.S., Chen J.G., and Groopman J.D. Translational strategies for cancer prevention in liver. Nat. Rev. Cancer 3 (2003) 321-329
3. Nakae D., Umemura T., and Kurokawa Y. Reactive oxygen and nitrogen oxide species-induced stress, a major intrinsic factor involved in carcinogenic processes and a possible target for cancer prevention. Asian Pac. J. Cancer Prev. 3 (2002) 313-318
4. Nishino H., Tokuda H., Murakoshi M., Satomi Y., Masuda M., Onozuka M., Yamaguchi S., Takayasu J., Tsuruta J., Okuda M., Khachik F., Narisawa T., Takasuka N., and Yano M. Cancer prevention by natural carotenoids. Biofactors 13 (2000) 89-94
5. Krinsky N.I., and Johnson E.J. Carotenoid actions and their relation to health and disease. Mol. Aspects Med. 26 (2005) 459-516
6. Khachik F., Beecher G.R., and Smith Jr. J.C. Lutein, lycopene, and their oxidative metabolites in chemoprevention of cancer. J. Cell Biochem. Suppl. 22 (1995) 236-246
7. Mares-Perlman J.A., Millen A.E., Ficek T.L., and Hankinson S.E. The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview. J. Nutr. 132 (2002) 518S-524S
8. Ribaya-Mercado J.D., and Blumberg J.B. Lutein and zeaxanthin and their potential roles in disease prevention. J. Am. Coll. Nutr. 23 (2004) 567S-587S
9. Vainio H., and Bianchini F. Evaluation of cancer-preventive agents and strategies a new program at the international agency for research on cancer. Ann. N.Y. Acad. Sci. 952 (2001) 177-180
10. Granado F., Olmedilla B., and Blanco I. Nutritional and clinical relevance of lutein in human health. Br. J. Nutr. 90 (2003) 487-502
11. Wattenberg L.W. Inhibition of tumorigenesis in animals. IARC Sci. Publ. 139 (1996) 151-158
12. Dragsted L.O. Natural antioxidants in chemoprevention. Arch. Toxicol. Suppl. 20 (1998) 209-226
13. Toledo L.P., Ong T.P., Pinho A.L., Jordao Jr. A., Vanucchi H., and Moreno F.S. Inhibitory effects of lutein and lycopene on placental glutathione S-transferase-positive preneoplastic lesions and DNA strand breakage induced in Wistar rats by the resistant hepatocyte model of hepatocarcinogenesis. Nutr. Cancer 47 (2003) 62-69
14. Solt D.T., and Farber E. New principle for the analysis of chemical carcinogenesis. Nature 263 (1976) 702-703
15. Semple-Roberts E., Hayes M.A., Armstrong D., Becker R.A., Racz W.J., and Farber E. Alternative methods of selecting rat hepatocellular nodules resistant to 2-acetylaminofluorene. Int. J. Cancer 40 (1987) 643-645
16. Hsu S.M., Raine L., and Fanger F.A. A comparative study of the dietary peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimunoassay antibodies. Am. J. Clin. Pathol. 75 (1981) 734-738
17. Squire R.A., and Levitt M.H. Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res. 35 (1975) 3214-3223
18. Olive P.L., Wlodek D., Duran R.E., and Banath J.P. Factors influencing DNA migration from individual cells subjected to gel electrophoresis. Exp. Cell Res. 198 (1992) 259-267
19. Sasaki Y.F., Sekihashi K., Izumiyama F., Nishidate E., Saga A., Ishida K., and Tsuda S. The comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP carcinogenicity database. Crit. Ver. Toxicol. 30 (2000) 629-799
20. Arnauld J., Fortis I., Blachier S., Kia D., and Favier A. Simultaneous determination of retinol, alpha-tocopherol and beta-carotene in serum by isocratic high-performance liquid cromatographic. J. Chromatogr. 572 (1991) 103-116
21. Barua A.B., Kostic D., and Olson J.A. New simplified procedures for the extraction and simultaneous high-performance liquid cromatographic analysis of retinol, tocopherols and carotenoids in humam serum. J. Chromatogr. 617 (1991) 257-264
22. Ong T.P., Heidor R., de Conti A., Dagli M.L., and Moreno F.S. Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase. Carcinogenesis 27 (2006) 1194-1203
23. Imai T., Masui T., Ichinose M., Nakanishi H., Yanai T., Masegi T., Muramatsu M., and Tatematsu M. Reduction of glutathione S-transferase P-form mRNA expression in remodeling nodules in rat liver revealed by in situ hybridization. Carcinogenesis 18 (1997) 545-551
24. Pelz R., Schmidt-Faber B., and Heseker H. Die Carotinoidzufuhr in der Nationalen Verzehersstudie. Z. Ernährungswiss 37 (1998) 319-327
25. Johnson-Down L., Saudny-Unterberger H., and Gray-Donald K. Food habits of canadians: lutein and lycopene intake in the canadian population. J. Am. Diet. Assoc. 102 (2002) 988-990
26. Institute of Medicine (IOM), Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids, National Academy Press, Washington, DC, 2000.
27. Kruger C.L., Murphy M., DeFreitas Z., Pfannkuch F., and Heimbach J. An innovative approach to the determination of safety for a dietary ingredient derived from a new source: case study using a crystalline lutein product. Food Chem. Toxicol. 40 (2002) 1535-1549
28. Jenkins M.Y., Mitchell G.V., and Grundel E. Natural tocopherols in a dietary supplement of lutein affect tissue distribution of tocopherols in young rats. Nutr. Cancer 37 (2000) 207-214
29. Khachik F., de Moura F.F., Zhao D.Y., Aebischer C.P., and Bernstein P.S. Transformations of selected carotenoids in plasma, liver, and ocular tissues of humans and in nonprimate animal models. Invest. Ophthalmol. Vis. Sci. 43 (2002) 3383-3392
30. Greenwald P. From carcinogenesis to clinical interventions for cancer prevention. Toxicology 166 (2001) 37-45
31. Kakizoe T. Chemoprevention of cancer-focusing on clinical trials. Jpn. J. Clin. Oncol. 33 (2003) 421-442
32. Jewell C., and O'Brien N.M. Effect of dietary supplementation with carotenoids on xenobiotic metabolizing enzymes in the liver, lung, kidney and small intestine of the rat. Br. J. Nutr. 3 (1999) 235-242
33. Chew B.P., Brown C.M., Park J.S., and Mixter P.F. Dietary lutein inhibits mouse mammary tumor growth by regulating angiogenesis and apoptosis. Anticancer Res. 23 (2003) 3333-3339
34. Kim J.M., Araki S., Kim D.J., Park C.B., Takasuka N., Baba-Toriyama H., Ota T., Nir Z., Khachik F., Shimidzu N., Tanaka Y., Osawa T., Uraji T., Murakoshi M., Nishino H., and Tsuda H. Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation. Carcinogenesis 19 (1998) 81-85
35. Moreno F.S., Rizzi M.B., Dagli M.L., and Penteado M.V. Inhibitory effects of beta-carotene on preneoplastic lesions induced in Wistar rats by the resistant hepatocyte model. Carcinogenesis 12 (1991) 1817-1822
36. Raju J., Swamy M.V., Cooma I., Patlolla J.M., Pittman B., Reddy B.S., Steele V.E., and Rao C.V. Low doses of beta-carotene and lutein inhibit AOM-induced rat colonic ACF formation but high doses augment ACF incidence. Int. J. Cancer 20 (2005) 798-802
37. Wang M., Tsao R., Zhang S., Dong Z., Yang R., Gong J., and Pei Y. Antioxidant activity, mutagenicity/anti-mutagenicity, and clastogenicity/anti-clastogenicity of lutein from marigold flowers. Food Chem. Toxicol. 44 (2006) 1522-1529
38. Kizzilian N., Wilkins R.C., Reinhardt P., Ferraroto C., Mc Lean J.R.N., and McNamee J.P. Silverstained comet assay for detection of apoptosis. Biotechniques 27 (1999) 926-930
39. Cliton S.K. Lycopene: chemistry, biology, and implications for human health desease. Nutr. Rev. 56 (1998) 35-51
40. Trosko J.E. The role of stem cells and gap junctions as targets for cancer chemoprevention and chemotherapy. Biomed. Pharmacother. 59 (2005) S326-S331